← Back to Search

Medication Optimization Intervention for HIV/AIDS (HIV-MOI Trial)

N/A

Waitlist Available

Led By Crystal K Hodge, PharmD

Research Sponsored by University of North Texas Health Science Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years of age or older

At least one of the following: hypertension or diabetes type 2

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

HIV-MOI Trial Summary

This trial will compare the health outcomes of two groups of African-Americans with HIV who either receive medication optimization with access to their medical records or usual care without access to records.

Who is the study for?

This trial is for adult African-Americans with HIV who also have high blood pressure, type 2 diabetes, or both. Participants must be willing to share their medical records and not be pregnant or have a life expectancy of less than 2 years.Check my eligibility

What is being tested?

The study tests if pharmacists improve health outcomes by accessing patients' medical records. Half will receive 'medication optimization' based on full records, while the other half gets standard counseling without record access.See study design

What are the potential side effects?

Since this trial involves medication optimization rather than new drugs, side effects are not a primary concern; however, changes in medication management could potentially lead to typical drug-related side effects depending on individual treatments.

HIV-MOI Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have either high blood pressure or type 2 diabetes.

HIV-MOI Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Diabetes mellitus

Hypertension

HIV-MOI Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Medication Optimization InterventionExperimental Treatment1 Intervention

This group will represent those participants whose medical records have been provided to the pharmacist.

Group II: Medication Optimization ControlActive Control1 Intervention

This group will represent those participants whose medical records have not been provided to the pharmacist.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of North Texas Health Science CenterLead Sponsor

39 Previous Clinical Trials

20,042 Total Patients Enrolled

University of MinnesotaOTHER

1,378 Previous Clinical Trials

1,588,379 Total Patients Enrolled

Walgreens, A Boots AllianceUNKNOWN

Media Library

Medication optimization intervention Clinical Trial Eligibility Overview. Trial Name: NCT03437694 — N/A

High Blood Pressure Research Study Groups: Medication Optimization Control, Medication Optimization Intervention

High Blood Pressure Clinical Trial 2023: Medication optimization intervention Highlights & Side Effects. Trial Name: NCT03437694 — N/A

Medication optimization intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT03437694 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this study actively seeking new participants?

"Clinicaltrials.gov reports that this medical experiment is not recruiting candidates at this time. This research program was initially posted on August 3rd 2018 and the last update occurred October 31st 2022, but there are 1592 other trials accepting participants right now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Impact of Providing Medical Records in a Patient-Centered, Community Pharmacy Based, HIV Care Model (HIV-MOI)

2018. "Impact of Providing Medical Records in a Patient-Centered, Community Pharmacy Based, HIV Care Model (HIV-MOI)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03437694.

All > Diabetes Type 2 > Hypertension